Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
27,212,732
-
Shares change
-
+869,231
-
Total reported value, excl. options
-
$1,151,636,509
-
Value change
-
+$26,731,112
-
Put/Call ratio
-
45%
-
Number of buys
-
83
-
Number of sells
-
-49
-
Price
-
$42.32
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2015
156 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q3 2015.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,212,732 shares
of 62,650,155 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (6,442,916 shares), FMR LLC (4,321,989 shares), Redmile Group, LLC (1,142,864 shares), VANGUARD GROUP INC (1,132,661 shares), FRANKLIN RESOURCES INC (1,032,310 shares), ALLIANCEBERNSTEIN L.P. (914,285 shares), Visium Asset Management, LP (902,948 shares), JPMORGAN CHASE & CO (899,460 shares), GILDER GAGNON HOWE & CO LLC (816,539 shares), and EAGLE ASSET MANAGEMENT INC (751,803 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.